Last reviewed · How we verify
FSR Peptide 200μM
At a glance
| Generic name | FSR Peptide 200μM |
|---|---|
| Sponsor | Xequel Bio, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FSR Peptide 200μM CI brief — competitive landscape report
- FSR Peptide 200μM updates RSS · CI watch RSS
- Xequel Bio, Inc. portfolio CI